Cian Healthcare Limited Relocates Corporate Office from Pune to New Delhi
Cian Healthcare Limited has relocated its corporate office from Pune to New Delhi, effective March 16, 2026, following board approval during a meeting held the same day. The company moved from Office No. 301 Konark Icon in Pune to Office No. 606, Ring Road Mall in New Delhi's Rohini sector. This operational change was disclosed to BSE Limited in compliance with SEBI Listing Regulations and relevant master circular requirements.

*this image is generated using AI for illustrative purposes only.
Cian Healthcare Limited has announced the relocation of its corporate office from Pune to New Delhi, marking a significant operational shift for the healthcare company. The decision was formally approved by the Board of Directors and communicated to BSE Limited in compliance with regulatory requirements.
Board Approval and Timeline
The Board of Directors of Cian Healthcare Limited approved the corporate office relocation during their physical meeting held on March 16, 2026. The meeting commenced at 02:00 P.M. (IST) and concluded at 03:38 P.M. (IST), with the relocation taking effect immediately from March 16, 2026.
Office Relocation Details
The company has provided specific details regarding the address change in its regulatory filing:
| Parameter: | Details |
|---|---|
| Previous Address: | Office No. 301 Konark Icon 3rd Floor, Mundhwa Kharadi Road Magarpatta Hadapsar, Pune-411028, Maharashtra, India |
| New Address: | Office No. 606, 6th Floor, Ring Road Mall, Sector 3, Rohini, New Delhi-110085 |
| Effective Date: | March 16, 2026 |
| Meeting Reference: | CHL/BM/2025-26/01 |
Regulatory Compliance
The disclosure was made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced compliance with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/1/3762/2026 dated January 30, 2026.
The announcement was signed by Rachit Malhotra, Company Secretary and Chief Compliance Officer (Membership No.: A39894), and submitted to BSE Limited under reference number CIAN/BSE/2025-26/23. The company trades on BSE with scrip code 542678 and trading symbol CHCL.


























